Status:

ACTIVE_NOT_RECRUITING

Development of a New Patient Reported Outcome Measure (PROM) to Assess Patient's Emotional Wellbeing, and Perceptions of Total Knee Replacement Surgery for the Treatment of Knee Arthritis

Lead Sponsor:

Invibio Ltd

Collaborating Sponsors:

Oxford University Innovation

Conditions:

Complete Questionnaires Following TKR Surgery

Eligibility:

All Genders

18+ years

Brief Summary

Development of a new Patient Reported Outcome Measure (PROM) to assess patient's emotional wellbeing, and perceptions of Total Knee Replacement surgery for the treatment of knee arthritis.

Detailed Description

Patients will complete the final developed questionnaire for quantitative analysis only (involves no administration of any medicinal products or medical devices) and is considered a low-risk project. ...

Eligibility Criteria

Inclusion

  • Patients aged 18 years of age or older.
  • Patients who have undergone Total Knee Replacement surgery with a metal implant for the treatment of end-stage knee arthritis in the last 3 months.
  • Patients who have only undergone one Total Knee Replacement surgery on the index knee.
  • Patients who, in the opinion of the Investigator, are able to understand this project and co-operate with the requirements of participation.
  • Patients who are able to give voluntary, written informed consent to participate in this project and from whom consent has been obtained.

Exclusion

  • Patients, who in the opinion of the Investigator, exhibit evidence of any condition or co-morbidity that would compromise their participation in the project.
  • Patients who are unable to understand and communicate fluently in English.
  • Patients who have experienced a complication following Total Knee Replacement surgery requiring a further hospital admission or revision surgery to the index knee.

Key Trial Info

Start Date :

October 7 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2026

Estimated Enrollment :

167 Patients enrolled

Trial Details

Trial ID

NCT06585267

Start Date

October 7 2024

End Date

April 1 2026

Last Update

November 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chapel Allerton Hospital

Leeds, United Kingdom, LS7 4SA